BFA
JUNO

BlackRock Fund Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

BlackRock Fund Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$40.5M Buy
2,146,963
+115,227
+6% +$2.82M 0.01% 1814
2016
Q3 		$61M Buy
2,031,736
+67,333
+3% +$2.09M 0.01% 1437
2016
Q2 		$75.5M Buy
1,964,403
+446,978
+29% +$18.6M 0.02% 1202
2016
Q1 		$57.8M Buy
1,517,425
+187,826
+14% +$6.54M 0.01% 1355
2015
Q4 		$58.5M Buy
1,329,599
+1,182,852
+806% +$58.7M 0.01% 1373
2015
Q3 		$5.97M Buy
146,747
+54,843
+60% +$2.41M ﹤0.01% 2694
2015
Q2 		$4.9M Buy
91,904
+15,001
+20% +$796K ﹤0.01% 2936
2015
Q1 		$4.67M Buy
+76,903
New +$3.73M ﹤0.01% 2879

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return